Phosphorylation-mediated activation and translocation of the cyclic AMP-specific phosphodiesterase PDE4D3 by cyclic AMP-dependent protein kinase and mitogen-activated protein kinases - A potential mechanism allowing for the coordinated regulation of PDE4D activity and targeting

被引:77
作者
Liu, HG
Maurice, DH
机构
[1] Queens Univ, Pharmaceut Mfg Assoc Canada, Hlth Res Fdn,Med Res Council Canada, Dept Pathol, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Dept Pharmacol & Toxicol, Kingston, ON K7L 3N6, Canada
关键词
D O I
10.1074/jbc.274.15.10557
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this study, we describe a novel mechanism by which a protein kinase C (PKC)-mediated activation of the Raf-extracellular signal-regulated kinase kinase (MEK)-extracellular signal-regulated kinase (ERK) cascade regulates the activity and membrane targeting of members of the cyclic AMP-specific phosphodiesterase D family (PDE4D), Using a combination of pharmacological and biochemical approaches, we show that increases in intracellular cAMP cause a protein kinase A-mediated phosphorylation and activation of the two PDE4D variants expressed in vascular smooth muscle cells, namely PDE4D3 and PDE4D5. In addition, we show that stimulation of PKC via the associated activation of the Raf-MEK-ERK cascade results in the phosphorylation and activation of PDE4D3 in these cells. Furthermore, our studies demonstrate that simultaneous activation of both the protein kinase A and PKC-Raf-MEK-ERK pathways allows for a coordinated activation of PDE4D3 and for the translocation of the particulate PDE4D3 to the cytosolic fraction of these cells. These data are presented and discussed in the context of the activation of the Raf-MEK-ERK cascade acting to modulate the activation and subcellular targeting of PDE4D gene products mediated by cAMP.
引用
收藏
页码:10557 / 10565
页数:9
相关论文
共 32 条
  • [1] ALVAREZ R, 1995, MOL PHARMACOL, V48, P616
  • [2] PRIMARY SEQUENCE OF CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE ISOZYMES AND THE DESIGN OF SELECTIVE INHIBITORS
    BEAVO, JA
    REIFSNYDER, DH
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (04) : 150 - 155
  • [3] The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase
    Beltman, J
    McCormick, F
    Cook, SJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (43) : 27018 - 27024
  • [4] A FAMILY OF HUMAN PHOSPHODIESTERASES HOMOLOGOUS TO THE DUNCE LEARNING AND MEMORY GENE-PRODUCT OF DROSOPHILA-MELANOGASTER ARE POTENTIAL TARGETS FOR ANTIDEPRESSANT DRUGS
    BOLGER, G
    MICHAELI, T
    MARTINS, T
    STJOHN, T
    STEINER, B
    RODGERS, L
    RIGGS, M
    WIGLER, M
    FERGUSON, K
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (10) : 6558 - 6571
  • [5] Bolger GB, 1997, BIOCHEM J, V328, P539
  • [6] DAVIS CW, 1979, J CYCLIC NUCL PROT, V5, P65
  • [7] A SYNTHETIC INHIBITOR OF THE MITOGEN-ACTIVATED PROTEIN-KINASE CASCADE
    DUDLEY, DT
    PANG, L
    DECKER, SJ
    BRIDGES, AJ
    SALTIEL, AR
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (17) : 7686 - 7689
  • [8] Challenge of human Jurkat T-cells with the adenylate cyclase activator forskolin elicits major changes in cAMP phosphodiesterase (PDE) expression by up-regulating PDE3 and inducing PDE4D1 and PDE4D2 splice variants as well as down-regulating a novel PDE4A splice variant
    Erdogan, S
    Houslay, MD
    [J]. BIOCHEMICAL JOURNAL, 1997, 321 : 165 - 175
  • [9] PROTEIN KINASE-A INHIBITORS ENHANCE RADIATION-INDUCED APOPTOSIS
    FINDIK, D
    SONG, QZ
    HIDAKA, H
    LAVIN, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 57 (01) : 12 - 21
  • [10] Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance
    Gekeler, V
    Boer, R
    Uberall, F
    Ise, W
    Schubert, C
    Utz, I
    Hofmann, J
    Sanders, KH
    Schachtele, C
    Klemm, K
    Grunicke, H
    [J]. BRITISH JOURNAL OF CANCER, 1996, 74 (06) : 897 - 905